IndraLab

Statements

COPS5 activates Prostatic Neoplasms. 2 / 2

| 1 1

eidos

"Inhibiting CSN5 strongly attenuates prostate cancer progression and could enhance PARP inhibition efficacy in the treatment of prostate cancer ."

34802033

➶

reach

"Inhibition of CSN5 can significantly repress multiple key oncogenic pathways in PC progression (eg, MYC, FOXM1, CTNNB1, and AUROR signaling) regardless of AR status."

34802033

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

COPS5 activates Prostatic Neoplasms. 2 / 2

INDRA sources:

Databases

Reading